Search results

Found 5,000 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Lilly to buy Janssen Animal Health

Eli Lilly is to buy Johnson & Johnson's animal health unit in Europe, expanding its businesses outside the generically-challenged pharmaceuticals sector. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/lilly_to_buy_janssen_animal_health_979430

Roche signs RNA pact with Santaris

Roche has linked up with Denmark's Santaris Pharma to discover and develop novel RNA targeted medicines. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_signs_rna_pact_with_santaris_1001336

Oxford BioMedica expands Pfizer pact

Oxford BioMedica has signed an amendment to broaden its licensing agreement with Pfizer regarding the development of therapeutics which target the company’s 5T4 tumour antigen for the treatment of cancer. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/oxford_biomedica_expands_pfizer_pact_981103

CHMP backs Almirall lung drug combo

Advisors to the European Medicines Agency have recommended approval of Almirall’s Duaklir, a combination therapy for chronic obstructive pulmonary disease that it is in the process of being sold to AstraZeneca. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/chmp_backs_almirall_lung_drug_combo_1002535

Watson launches generic Actos

Having sued the Food and Drug Administration in the summer, Watson Pharmaceuticals has launched its generic versions of Takeda's blockbuster diabetes drug Actos in the USA which have received the agency's final approval. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/watson_launches_generic_actos_976357

Europe approval for GSK/Theravance COPD drug

GlaxoSmithKline and partner Theravance are celebrating after the European Commission granted marketing authorisation for their chronic obstructive pulmonary disease Anoro. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/europe_approval_for_gsktheravance_copd_drug_1001914

Skyepharma's Flutiform in COPD trials

The UK’s Skyepharma says that partner Mundipharma has commenced an international clinical trial of the firms’ asthma drug Flutiform for the treatment of chronic obstructive pulmonary disease.  - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/skyepharmas_flutiform_in_copd_trials_1005720

Over 800 jobs to go at B-MS

Bristol-Myers Squibb is the latest drugmaker to announce major lay-offs and reports suggest  that 3% of its global workforce could be cut. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/over_800_jobs_to_go_at_b-ms_982365

Losses more than halve at Vernalis

Vernalis of the UK has posted a very healthy set of financials for the first six months. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/losses_more_than_halve_at_vernalis_976858

Bayer eyes expansion in Africa

While the emerging markets already making up a third of its healthcare sales last year, Bayer is looking at further opportunities, specifically in Africa. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/bayer_eyes_expansion_in_africa_1001687

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download